NRX Pharmaceuticals Balance Sheet (2024-2025) | NRXP

Balance Sheet Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 1.32M1.90M1.60M1.44M5.55M2.90M7.20M7.80M
Cash & Current Investments (Quarter) 1.32M1.90M1.60M1.44M5.55M2.90M7.20M7.80M
Receivables - Net (Quarter) 0.01M0.24M0.16M
Receivables - Other (Quarter) 0.01M0.01M
Receivables (Quarter) 0.01M0.24M0.16M
Prepaid Assets (Quarter) 0.43M0.65M0.42M0.21M0.55M0.09M0.34M0.93M
Current Assets (Quarter) 3.35M4.88M4.11M3.30M7.26M4.59M11.95M8.89M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.01M0.07M0.06M
Long-Term Investments (Quarter) 0.40M
Goodwill (Quarter) 0.61M1.79M
Intangibles (Quarter) 1.78M0.93M
Goodwill & Intangibles (Quarter) 2.39M2.72M
Other Non-Current Assets (Quarter) 0.44M0.38M0.36M0.34M0.33M0.25M0.24M0.25M
Non-Current Assets (Quarter) 0.44M0.38M0.36M0.35M0.33M0.25M3.05M4.06M
Assets (Quarter) 3.79M5.26M4.46M3.65M7.59M4.84M15.00M12.96M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 6.26M5.01M4.87M4.13M4.31M3.63M4.26M4.27M
Notes Payables (Quarter) 3.05M1.25M8.40M9.85M9.91M
Payables (Quarter) 6.26M5.01M7.92M5.38M12.71M13.48M14.17M4.27M
Accumulated Expenses (Quarter) 5.30M9.59M9.44M10.15M0.55M9.97M9.88M0.50M
Other Accumulated Expenses (Quarter) 0.99M0.21M0.24M0.47M0.20M0.05M0.10M0.00M
Short term Debt (Quarter) 0.03M0.94M1.90M0.32M9.85M16.27M0.15M
Current Leases (Quarter) 0.10M0.21M
Total Current Liabilities (Quarter) 20.30M21.86M32.75M40.45M40.59M28.58M
Non-Current Liabilities
Convertible Debt (Quarter) 7.65M2.98M5.01M
Operating Leases (Quarter) 0.14M0.63M
Other Non-Current Liabilities (Quarter) 0.01M1.90M5.64M9.85M16.27M15.86M12.30M
Total Non-Current Liabilities (Quarter) 23.65M21.38M21.23M22.90M24.19M24.89M16.59M
Total Liabilities (Quarter) 18.86M23.66M23.28M26.87M32.75M40.45M40.75M28.89M
Shareholder's Equity
Total Debt (Quarter) 0.03M0.94M1.90M0.32M9.85M16.27M0.15M
Common Equity (Quarter) -15.07M-18.39M-18.82M-23.22M-25.16M-35.62M-25.75M-15.90M
Shareholder's Equity (Quarter) -15.07M-18.39M-18.82M-23.22M-25.16M-35.62M-25.75M-15.94M
Liabilities and Shareholders Equity (Quarter) 3.79M5.26M4.46M3.65M7.59M4.84M15.00M12.96M
Retained Earnings (Quarter) -0.00M-267.57M-278.27M-283.79M-301.37M-307.30M-306.89M
Treasury Shares (Quarter) 0.07M0.07M0.03M0.03M